These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30201848)

  • 1. Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome.
    Mathew AV; Li L; Byun J; Guo Y; Michailidis G; Jaiswal M; Chen YE; Pop-Busui R; Pennathur S
    Diabetes Care; 2018 Nov; 41(11):2431-2437. PubMed ID: 30201848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease.
    Wang G; Mathew AV; Yu H; Li L; He L; Gao W; Liu X; Guo Y; Byun J; Zhang J; Chen YE; Pennathur S
    PLoS One; 2018; 13(3):e0193782. PubMed ID: 29505607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus.
    Smith CK; Vivekanandan-Giri A; Tang C; Knight JS; Mathew A; Padilla RL; Gillespie BW; Carmona-Rivera C; Liu X; Subramanian V; Hasni S; Thompson PR; Heinecke JW; Saran R; Pennathur S; Kaplan MJ
    Arthritis Rheumatol; 2014 Sep; 66(9):2532-2544. PubMed ID: 24838349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight Loss and Exercise Alter the High-Density Lipoprotein Lipidome and Improve High-Density Lipoprotein Functionality in Metabolic Syndrome.
    Khan AA; Mundra PA; Straznicky NE; Nestel PJ; Wong G; Tan R; Huynh K; Ng TW; Mellett NA; Weir JM; Barlow CK; Alshehry ZH; Lambert GW; Kingwell BA; Meikle PJ
    Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):438-447. PubMed ID: 29284607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis.
    Vivekanandan-Giri A; Slocum JL; Byun J; Tang C; Sands RL; Gillespie BW; Heinecke JW; Saran R; Kaplan MJ; Pennathur S
    Ann Rheum Dis; 2013 Oct; 72(10):1725-31. PubMed ID: 23313808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifestyle intervention enhances high-density lipoprotein function among patients with metabolic syndrome only at normal low-density lipoprotein cholesterol plasma levels.
    Hansel B; Bonnefont-Rousselot D; Orsoni A; Bittar R; Giral P; Roussel R; Marre M; Mohammedi K; Bruckert E; Chapman MJ; Kontush A
    J Clin Lipidol; 2016; 10(5):1172-81. PubMed ID: 27678434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lifestyle intervention with an energy-restricted Mediterranean diet and physical activity enhances HDL function: a substudy of the PREDIMED-Plus randomized controlled trial.
    Sanllorente A; Soria-Florido MT; Castañer O; Lassale C; Salas-Salvadó J; Martínez-González MÁ; Subirana I; Ros E; Corella D; Estruch R; Tinahones FJ; Hernáez Á; Fitó M
    Am J Clin Nutr; 2021 Nov; 114(5):1666-1674. PubMed ID: 34582548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.
    Shao B; Tang C; Sinha A; Mayer PS; Davenport GD; Brot N; Oda MN; Zhao XQ; Heinecke JW
    Circ Res; 2014 May; 114(11):1733-42. PubMed ID: 24647144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.
    Zheng L; Nukuna B; Brennan ML; Sun M; Goormastic M; Settle M; Schmitt D; Fu X; Thomson L; Fox PL; Ischiropoulos H; Smith JD; Kinter M; Hazen SL
    J Clin Invest; 2004 Aug; 114(4):529-41. PubMed ID: 15314690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structured lifestyle intervention in patients with the metabolic syndrome mitigates oxidative stress but fails to improve measures of cardiovascular autonomic neuropathy.
    Pennathur S; Jaiswal M; Vivekanandan-Giri A; White EA; Ang L; Raffel DM; Rubenfire M; Pop-Busui R
    J Diabetes Complications; 2017 Sep; 31(9):1437-1443. PubMed ID: 28709739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins.
    Malle E; Marsche G; Panzenboeck U; Sattler W
    Arch Biochem Biophys; 2006 Jan; 445(2):245-55. PubMed ID: 16171772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions.
    Shao B; Pennathur S; Heinecke JW
    J Biol Chem; 2012 Feb; 287(9):6375-86. PubMed ID: 22219194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathway.
    Shao B; Heinecke JW
    J Proteomics; 2011 Oct; 74(11):2289-99. PubMed ID: 21501700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a one-year lifestyle modification program on cholesterol efflux capacities in men with abdominal obesity and dyslipidemia.
    Boyer M; Mitchell PL; Poirier P; Alméras N; Tremblay A; Bergeron J; Després JP; Arsenault BJ
    Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E460-E468. PubMed ID: 29870675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol efflux capacity and its association with prevalent metabolic syndrome in a multi-ethnic population (Dallas Heart Study).
    Akinmolayemi O; Saldanha S; Joshi PH; Deodhar S; Ayers CR; Neeland IJ; Rohatgi A
    PLoS One; 2021; 16(9):e0257574. PubMed ID: 34547056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study.
    Annema W; Dikkers A; de Boer JF; van Greevenbroek MMJ; van der Kallen CJH; Schalkwijk CG; Stehouwer CDA; Dullaart RPF; Tietge UJF
    Sci Rep; 2016 Jun; 6():27367. PubMed ID: 27270665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of dysfunctional high-density lipoprotein by myeloperoxidase.
    Nicholls SJ; Zheng L; Hazen SL
    Trends Cardiovasc Med; 2005 Aug; 15(6):212-9. PubMed ID: 16182131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex.
    Huang Y; Wu Z; Riwanto M; Gao S; Levison BS; Gu X; Fu X; Wagner MA; Besler C; Gerstenecker G; Zhang R; Li XM; DiDonato AJ; Gogonea V; Tang WH; Smith JD; Plow EF; Fox PL; Shih DM; Lusis AJ; Fisher EA; DiDonato JA; Landmesser U; Hazen SL
    J Clin Invest; 2013 Sep; 123(9):3815-28. PubMed ID: 23908111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial.
    Salas-Salvadó J; Díaz-López A; Ruiz-Canela M; Basora J; Fitó M; Corella D; Serra-Majem L; Wärnberg J; Romaguera D; Estruch R; Vidal J; Martínez JA; Arós F; Vázquez C; Ros E; Vioque J; López-Miranda J; Bueno-Cavanillas A; Tur JA; Tinahones FJ; Martín V; Lapetra J; Pintó X; Daimiel L; Delgado-Rodríguez M; Matía P; Gómez-Gracia E; Díez-Espino J; Babio N; Castañer O; Sorlí JV; Fiol M; Zulet MÁ; Bulló M; Goday A; Martínez-González MÁ;
    Diabetes Care; 2019 May; 42(5):777-788. PubMed ID: 30389673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein.
    Shao B; Oda MN; Oram JF; Heinecke JW
    Chem Res Toxicol; 2010 Mar; 23(3):447-54. PubMed ID: 20043647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.